Items per page
1 - 40 of 40
Title Published in Access level OA Policy Year Views Downloads
Self-assembled proteomimetic (SAP) with antibody-like binding from short PNA–peptide conjugatesProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2025 71 73
One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19The Pediatric infectious disease journal
accessLevelPublic
2024 66 80
SARS-CoV-2 viral load and shedding kineticsNature reviews. Microbiology
accessLevelPublic
2023 209 102
Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatusPloS one
accessLevelPublic
2023 103 41
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responsesEBioMedicine
accessLevelPublic
2023 112 173
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 199 42
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
accessLevelPublic
2023 305 73
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemicPloS one
accessLevelPublic
2022 167 147
Applying mixture model methods to SARS-CoV-2 serosurvey data from GenevaEpidemics
accessLevelPublic
2022 193 94
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological studyBMJ open
accessLevelPublic
2022 114 45
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 84 0
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaNature
accessLevelPublic
2022 1,447 201
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 437 125
COVID-19-related school disruptions and well-being of children and adolescents in GenevaJournal of paediatrics and child health
accessLevelPublic
2022 150 115
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 282 153
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2Nature medicine
accessLevelPublic
2022 274 149
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 195 132
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyNature Communications
accessLevelPublic
2021 436 187
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 372 38
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 433 235
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 520 305
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 306 126
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroconversion and occupational exposure of employees at a Swiss university hospital: A large longitudinal cohort studyInfection Control and Hospital Epidemiology
accessLevelPublic
2021 312 186
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceClinical Microbiology and Infection
accessLevelPublic
2021 299 254
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 403 198
Waning antibodies to SARS-CoV-2 - Don't panicThe Lancet Regional Health. Europe
accessLevelPublic
2021 172 70
Sero-molecular epidemiology of hepatitis E virus in pigs and human contacts in GhanaOne Health Outlook
accessLevelPublic
2021 254 98
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 407 244
A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samplesProceedings of the National Academy of Sciences
accessLevelPublic
2021 344 216
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialEClinicalMedicine
accessLevelPublic
2021 637 145
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 338 168
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)Emerging Microbes & Infections
accessLevelPublic
2020 457 198
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
accessLevelPublic
2020 512 289
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet
accessLevelRestricted
2020 772 14
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 453 385
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 376 190
SARS-CoV-2 seroprevalence in COVID-19 hotspotsThe Lancet
accessLevelPublic
2020 348 102
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 517 195
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trialBMJ Open
accessLevelPublic
2020 266 103
Link of a ubiquitous human coronavirus to dromedary camelsProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
2016 226 123
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack